galcanezumab 100 mg / 1 mL (1 mL INJECTION)
|
$372.1500
|
|
VA Big4
|
|
EMGALITY (3) |
Eli Lilly & Company |
|
galcanezumab 100 mg / 1 mL (1 mL INJECTION)
|
$488.1700
|
|
VA FSS
|
|
EMGALITY (3) |
Eli Lilly & Company |
|
galcanezumab 100 mg / 1 mL (1 mL INJECTION)
|
$504.3633
|
|
NADAC
|
brand
|
EMGALITY (1) |
Eli Lilly and Company |
|
galcanezumab 120 mg / 1 mL (1 mL INJECTION)
|
$424.0500
|
|
VA Big4
|
|
EMGALITY (1) |
Eli Lilly & Company |
|
galcanezumab 120 mg / 1 mL (1 mL INJECTION)
|
$425.1600
|
|
VA Big4
|
|
EMGALITY (1) |
Eli Lilly & Company |
|
galcanezumab 120 mg / 1 mL (1 mL INJECTION)
|
$585.8100
|
|
VA FSS
|
|
EMGALITY (1) |
Eli Lilly & Company |
EMGALITY (1) |
Eli Lilly & Company |
|
galcanezumab 120 mg / 1 mL (1 mL INJECTION)
|
$607.0585
|
|
NADAC
|
brand
|
EMGALITY (1) |
Eli Lilly and Company |
|
galcanezumab 120 mg / 1 mL (1 mL INJECTION)
|
$608.0123
|
|
NADAC
|
brand
|
EMGALITY (1) |
Eli Lilly and Company |
|